Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has axed its own once-monthly twin GLP-1/ GIP receptor agonist, ending (PDF) advanceme...

Daiichi pays Merck $170M to develop lung cancer cells T-cell engager treaty

.Merck &amp Co. has rapidly made back some of the expenses of its Harp on Rehabs buyout, pulling in ...

BioMarin stops preclinical gene therapy for heart disease

.After BioMarin conducted a spring season clean of its pipe in April, the firm has actually made a d...

Eisai vegetations molecular glue SEED with $1.5 B biobucks work

.Large Pharmas stay caught to the concept of molecular glue degraders. The most up to date business ...

Life scientific research credit scores firm reveals with $600M

.A brand new worldwide lifestyle scientific research credit history agency, nicknamed Symbiotic Fund...

BMS trenches TIGIT, ignoring $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing another huge wager from the Caforio period, terminating a pa...

Nuvation standstills BET prevention after thinking about stage 1 record

.After taking a look at phase 1 data, Nuvation Bio has determined to stop focus on its single top BD...

' Professional intuition' led FDA consultants to back Zevra's rare illness med

.Zevra Therapies' uncommon condition drug seems to be to be on the course to permission this autumn ...

Pfizer takes $230M hit after axing stopped working DMD genetics therapy

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has blown a $230 mi...

AC Immune sees 'site' potential in Alzheimer's medicine information

.After greater than 20 years of work with neurodegenerative diseases, Swiss biotech air conditioner ...